Search

everythinglearnresearchcommunity

for

Search:↓

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Monkeys with hair loss during pregnancy showed higher stress hormone levels and invested differently in their offspring.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

SHBG may be a useful early indicator and treatment target for PCOS.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Higher androgen levels do not cause baldness in men.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Gray hair regained color after thyroid hormone treatment.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

Thyroid function may influence hair loss after COVID-19.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.